N@N

Biosign Technologies Expands Strategic Alliance with HealthSaas to include Cloud Dx Solution

^{Published on 2011-09-26 05:00:37 - Market Wire}
 

TORONTO, Sept. 26, 2011 /CNW/ - Biosign Technologies Inc. (TSXV: BIO) has announced an expansion of their strategic alliance with HealthSaaS, Inc to add the Cloud Dx^TM solution and non-invasive blood glucose measurements to the HealthSaaS Connected Outcomes Framework®.

Frank Ille, CEO, HealthSaaS stated "Our partnership will allow Connected Outcomes Framework® services to deliver a broad range of data and analytics that will measurably improve the quality of life for patients and lower costs to providers and payers."

The CloudDx^TM solution and UFIT® device integrated with HealthSaaS Connected Outcomes Framework® will deliver sophisticated, reliable personal health monitoring that augments patient and disease management. The alliance will provide accurate, secure vitals monitoring, including blood pressure and glucose analysis with integrated real-time reporting to the complete circle of care (patient, family, nurses, physicians, healthcare provider, and payer).

Dr. Scott Jenkins, CEO of BioSign stated "Our New Cloud Dx^TM solution and non-invasive blood glucose data integrated with HealthSaaS Connected Outcomes Framework® services is a significant step forward to facilitating seamless collaboration and providing quality metrics for the healthcare ecosystem. By working together, we plan to lower the costs for payers and at the same time improve the quality of life for patients with diabetes, hypertension, and cardio-vascular diseases."

About HealthSaaS, Inc.

At HealthSaaS we have a genuine curiosity that inspires us to think differently. We exist to challenge the status quo and are driven by a sense of purpose to empower every segment of the healthcare system. Our vision allows us to create solutions that enhance provider efficiencies, track outcomes and improve the quality of life for patients throughout the continuum of care. For more information visit: [ www.healthsaas.net ]

About Biosign Technologies Inc

Biosign Technologies Inc. (TSXV: BIO) provides biomedical systems through its Cloud Dx^TM branded solution. Cloud Dx^TM applications include intelligent systems for non-invasive monitoring of common health risks associated with blood pressure, glucose, and medication. Biosign technology combines measurement, analysis, and tools for disease and patient management to support global vital health monitoring. The UFIT® medical device delivers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation and management, and remote patient monitoring. For more information visit: [ www.biosign.com ].

Forward-Looking Statements

This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Biosign's actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forward-looking information please refer to risk factors detailed in, as well as other information contained in, Biosign's filings with Canadian securities regulators ([ www.sedar.com ]).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.